SEC Form 4
Anixa Biosciences, Inc. (ANIX) insider trading
In the 12 months to Oct 26, 2026, 4 ANIX insiders reported open-market purchases of $482.1K across 19 filings; no open-market sales were filed.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $0
- 0 filings · 0 insiders
- Open-market purchases
- $482.1K
- 19 filings
Who traded ANIX, and when
- Purchase
ANIX daily close from Oct 27, 2025 to Oct 26, 2026, between $2.35 and $5.22, last $2.94. 0 sale and 19 purchase filings by 4 insiders, marked at their filing dates. Lewis H. Titterton jr., Director: bought $217.5K across 5 filings, first filed Jun 17, 2026, last Sep 25, 2026. Amit Kumar, Chief Executive Officer: bought $204.8K across 11 filings, first filed Jun 16, 2026, last Oct 22, 2026. Arnold M. Baskies, Director: bought $44.2K across 2 filings, first filed Jan 29, 2026, last Sep 28, 2026. Michael Catelani, President, COO, & CFO: bought $15.6K across 1 filing, first filed Sep 30, 2026, last Sep 30, 2026.
Largest mark · tap a row for others
Lewis H. Titterton jr. · Director
Purchase $131,907
49,036 shares at $2.69 avg
Filed Sep 25, 2026 · traded Sep 23
Close on filing date $2.78
Lewis H. Titterton jr. · Director
Director
$217.5K boughtAmit Kumar · Chief Executive Officer
Chief Executive Officer
$204.8K boughtArnold M. Baskies · Director
Director
$44.2K boughtMichael Catelani · President, COO, & CFO
President, COO, & CFO
$15.6K boughtOpen-market trades
19 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Lewis H. Titterton jr. | Director | — | $217.5K | 5 | — | |
| Amit Kumar | Chief Executive Officer | — | $204.8K | 11 | — | |
| Arnold M. Baskies | Director | — | $44.2K | 2 | — | |
| Michael Catelani | President, COO, & CFO | — | $15.6K | 1 | — |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Amit Kumar Chief Executive Officer | Purchase | 8,000 | $2.72 | $21.8K | 680,000 | |
traded | Michael Catelani President, COO, & CFO | Purchase | 5,500 | $2.84 | $15.6K | 50,000 | |
traded | Arnold M. Baskies Director | Purchase | 5,000 | $2.76 | $13.8K | 140,572 | |
traded | Amit Kumar Chief Executive Officer | Purchase | 7,000 | $2.78 | $19.5K | 672,000 | |
traded | Lewis H. Titterton jr. Director | Purchase | 49,036 | $2.69 | $131.9K | 1,046,003 | |
traded | Lewis H. Titterton jr. Director | Purchase | 10,000 | $2.73 | $27.3K | 996,967 | |
traded | Amit Kumar Chief Executive Officer | Purchase | 3,000 | $2.75 | $8.3K | 665,000 | |
traded | Amit Kumar Chief Executive Officer | Purchase | 5,000 | $2.76 | $13.8K | 662,000 | |
traded | Amit Kumar Chief Executive Officer | Purchase | 5,000 | $3.47 | $17.4K | 657,000 | |
traded | Amit Kumar Chief Executive Officer | Purchase | 5,000 | $3.44 | $17.2K | 652,000 | |
traded | Amit Kumar Chief Executive Officer | Purchase | 3,000 | $3.73 | $11.2K | 643,812 | |
traded | Amit Kumar Chief Executive Officer | Purchase | 3,188 | $3.37 | $10.7K | 647,000 | |
traded | Amit Kumar Chief Executive Officer | Purchase | 5,000 | $3.46 | $17.3K | 640,812 | |
traded | Lewis H. Titterton jr. Director | Purchase | 12,000 | $3.47 | $41.6K | 986,967 | |
traded | Lewis H. Titterton jr. Director | Purchase | 2,797 | $3.28 | $9.2K | 974,967 | |
traded | Amit Kumar Chief Executive Officer | Purchase | 5,000 | $3.04 | $15.2K | 635,812 | |
traded | Lewis H. Titterton jr. Director | Purchase | 2,836 | $2.64 | $7.5K | 972,170 | |
traded | Amit Kumar Chief Executive Officer | Purchase | 21,000 | $2.50 | $52.5K | 630,812 | |
traded | Arnold M. Baskies Director | Purchase | 10,000 | $3.04 | $30.4K | 135,000 |
GET /stocks/filings/vX/form-4?tickers=ANIX&filing_date.gte=2025-10-26&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"ANIX"
],
"issuer_cik": "0000715446",
"owner_cik": "0001191905",
"accession_number": "0001493152-26-048144",
"form_type": "4",
"filing_date": "2026-10-22",
"period_of_report": "2026-10-22",
"issuer_name": "Anixa Biosciences Inc",
"issuer_trading_symbol": "ANIX",
"owner_name": "KUMAR AMIT",
"is_director": true,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "Chief Executive Officer",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-10-22",
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 8000,
"transaction_price_per_share": 2.72,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 680000,
"transaction_value": 21760,
"not_subject_to_section_16": false,
"direct_or_indirect": "D"
},
{
"tickers": [
"ANIX"
],
"issuer_cik": "0000715446",
"owner_cik": "0001689394",
"accession_number": "0001493152-26-045053",
"form_type": "4",
"filing_date": "2026-09-30",
"period_of_report": "2026-09-30",
"issuer_name": "Anixa Biosciences Inc",
"issuer_trading_symbol": "ANIX",
"owner_name": "Catelani Michael",
"is_director": false,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "President, COO, & CFO",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-09-30",
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 5500,
"transaction_price_per_share": 2.84,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 50000,
"transaction_value": 15620,
"not_subject_to_section_16": false,
"direct_or_indirect": "D"
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 5 records
- Option exercises3 records
- Tax withholding2 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
Frequently asked questions
Has Anixa Biosciences, Inc.'s CEO sold stock?
No. Amit Kumar (CEO) made no open-market sales filed as CEO in the last 12 months.
How current is ANIX’s insider data?
These are ANIX Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.
What counts as an open-market buy or sell?
Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.
Build with AI
Track ANIX insider trades with your agent
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for ANIX every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.